Author:
O’Shaughnessy J.A.,Denicoff A.M.,Venzon D.J.,Danforth D.,Pierce L.J.,Frame J.N.,Bastian A.,Ghosh B.,Goldspiel B.,Miller L.,Dorr F.A.,Keegan P.,Ben-Bamch N.,Mrose H.,Noone M.,Cowan K.H.
Reference56 articles.
1. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer;Hryniuk;J Clin Oncol,1986
2. Analysis of dose intensity in doxorubicin-containing adjuvant chemotherapy in stage II and III breast carcinoma;Ang;J Clin Oncol,1989
3. Initial findings o CALGB 8541 A dose and dose-intensity trial of cyclophosphamide (C), doxorubicin (A), and 5-fluorouracil (F) as adjuvant treatment of stage II, node + male breast cancer;Budman;Proc Amer Soc Clin Oncol,1992
4. The importance of dose intensity in chemotherapy of metastatic breast cancer;Hryniuk;J Clin Oncol,1984
5. A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy;Antman;J Clin Oncol,1992
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献